Brazil’s President Jair Bolsonaro said last week China lacked the creditability to develop a cure for the coronavirus.
Whoops.
Now a Sao Paulo research centre, partnered with China's Sinovac Biotech Ltd, was granted “exceptional” permission to bring six million doses fo the COVID-19 drug into the country for phase three trials.
